ads

Ads

  • Home
  • Eye Health
  • Men Health
  • Women Health

Ads2

Health & Wellness

A recent analysis of gender differences in research reporting has found that female scientists are less likely to use positive language to frame their findings than their male counterparts.

scientists looking at screenShare on Pinterest
There are some key gender differences in the way that scientists present their findings.

Clinical articles with male first or last authors were more likely to contain terms such as "unprecedented" and "unique" in their titles or abstracts than those with female first and last authors.

The new BMJ study also found that articles that contain such terms are more likely to have higher rates of subsequent citation.

A scientist's rate of citation — that is, how often other articles reference their work — can impact their career prospects, note the study authors, who hail from the University of Mannheim in Germany, Yale University School of Management in New Haven, CT, and Harvard Medical School in Boston, MA.

"Citations are often used to gauge a researcher's influence, and many organizations use cumulative citations explicitly in their decisions regarding recruitment, promotion, pay, and funding," they write.

Gender disparity is a complex issue

In their study paper, the authors outline the gender disparities present in research communities such as the life sciences and academic medicine.

Not only are females in the minority, but they also earn less and win fewer research grants than males. In addition, their articles tend to gain fewer citations than those of their male colleagues.

"The factors that underlie gender disparities in academia are many and complex," says senior study author Dr. Anupam Jena, "but it is important to be aware that language may also play a role — as both a driver of inequality and as a symptom of gender differences in socialization."

Dr. Jena is an associate professor of Health Care Policy at Harvard Medical School. He is also an assistant physician in the Department of Medicine at Massachusetts General Hospital in Boston.

He and his colleagues set out to analyze whether or not females and males differ in how positively they express their research findings.

They also wanted to find out whether or not a link exists between such positive framing and higher subsequent citation rates.

Methods and key findings

In total, the team analyzed more than 101,000 clinical research articles and around 6.2 million general life sciences articles that PubMed had published during 2002–2017.

They searched all the titles and abstracts of the articles for use of 25 positive terms, including "unprecedented," "unique," "excellent," and "novel."

Using a software tool called Genderize, they then determined the likely gender of the first and last author of each article using their first name.

In addition, with help from other established tools, they determined the journal impact and rate of citations of each article.

Their analysis revealed that:

  • Articles with female first and last authors were 12.3% less likely, on average, to frame the findings in positive terms, compared with articles that had male first or last authors.
  • This gender difference was even greater in high impact journals, where females were 21.4% less likely to use positive terms to describe their findings.
  • On average, for clinical journals, the use of positive terms was linked to a 9.4% higher rate of subsequent citations.
  • For high impact clinical journals, the use of positive terms was linked to a 13% higher rate of subsequent citations.

"Results were similar when broadened to general life science articles published in journals indexed by PubMed," the study authors remark, "suggesting that gender differences in positive word use generalize to broader samples."

The researchers say that the findings are in line with those of studies that suggest peer reviewers generally use a higher standard in judging the work of female scientists.

As the study was an observational one, it cannot establish the direction of cause and effect. For instance, it cannot say whether the use of positive language is a driver or consequence of inequality.

However, the results held up after the researchers adjusted them to take out potential influencers, such as field of research, journal impact factor, and year of publication. This suggests that the link is robust.

'Fix the systems, not the women'

The researchers accept that their analysis had a number of limitations. For instance, they were not able to compare the relative scientific merits of the articles or determine the extent to which the editors may have influenced the choice of language.

They argue, however, that the findings show a clear trend in life sciences and academic medicine of regarding studies with male leaders as more important.

In a linked editorial, Dr. Reshma Jagsi, a professor at the University of Michigan in Ann Arbor, and Dr. Julie K. Silver, an associate professor at Harvard Medical School, comment on the research.

To respond with a "fix the women," approach, they say, would show a lack of understanding of the evidence surrounding gender equity.

Instead of asking females to use more positive language in framing their research, they suggest that the focus should be on encouraging males to use a little restraint.

"We must fix the systems that support gender disparities," they argue, urging all those who produce, edit, and consume scientific literature "to counteract bias in order to optimally advance science."

"As a society, we want the best work to rise to the top on its own merits — how it helps us understand and improve health — not based on the gender of the researchers or on the researchers' own opinion about whether their work is groundbreaking."

Dr. Anupam Jena


Read More

Asexuality describes a lack of sexual attraction. Asexual people may experience romantic attraction, but they do not feel the urge to act on these feelings sexually.

Asexuality is a sexual orientation, like being gay or straight. It is different from celibacy or abstinence. Asexuality exists on a spectrum, with much diversity in people's experiences and desires for relationships, attraction, and arousal.

An estimated 1% of the population is asexual, though experts believe the numbers could be higher.

This article looks at what asexuality is, what it is not, and some of the spectrums that people may identify with.

Asexuality is a sexual orientation, just like homosexuality, bisexuality, and heterosexuality. Asexual people are sometimes known as ace or aces for short.

According to The Trevor Project, asexual is an umbrella term that exists on a spectrum. It describes a variety of ways in which a person might identify. While most asexual people have little interest in having sex, they may experience romantic attraction. Others may not.

Asexual people have the same emotional needs as everyone else. Most will desire and form emotionally intimate relationships with other people. Asexual people may be attracted to the same sex or other sexes.

Every asexual person will have a different experience, which may include:

  • falling in love
  • experiencing arousal
  • having orgasms
  • masturbating
  • getting married
  • having children

In the initialism LGBTQIAP+, the A stands for asexual spectrum, or a-spec. Several identities fall under this category.

Asexual people have the same emotional needs as everyone else. Everyone is different, and how individuals fulfill those needs varies widely.

Some aces may want romantic relationships. They can feel romantically attracted to other people, which may include the same sex or other sexes.

Other aces prefer close friendships to intimate relationships. Some will experience arousal, and some will masturbate while having no interest in having sex with another person.

Some asexual people do not want to have sexual contact, while others may feel "sex-neutral." Other asexual people will engage in sexual contact to gain an emotional connection.

Other common identities which fall into the asexual spectrum include:

Aromantic

Aromantic people experience little or no romantic attraction. They prefer close friendships and other nonromantic relationships.

Many aromantic people will form queer platonic partnerships, or QPPs. QPPs are platonic yet have the same level of commitment as romantic relationships. Some people in QPPs choose to live together or have children together.

Demisexual

People who are demisexual experience sexual or romantic attraction, but only after they have formed a close, emotional connection with someone.

Graysexual or grayromantic

Graysexual or grayromantic people identify somewhere between sexual and asexual. This can include but is not limited to:

  • people who only experience romantic attraction sometimes
  • people who only experience sexual attraction sometimes
  • people who experience sexual attraction but have a very low sex drive
  • people who desire and enjoy sexual or romantic relationships but only in very specific circumstances

Asexuality is a sexual orientation. Typically, an asexual person would always have had little interest in sexual contact with other people. It is not the same as suddenly losing interest in sex or choosing to abstain from sex while still experiencing sexual attraction.

Asexuality is not the same as celibacy or abstinence. If someone is celibate or abstains from sex, this means they have taken a conscious decision to not take part in sexual activity despite experiencing sexual attraction.

It is also important to note that asexuality is not the same as hypoactive sexual desire disorder or sexual aversion disorder. These are medical conditions associated with anxiety towards sexual contact. Social pressure may make asexual people feel anxious about sex, but that is different.

Asexuality is not:

  • abstinence on religious grounds
  • sexual repression, aversion, or dysfunction
  • a fear of intimacy
  • loss of libido due to age, illness, or other circumstances

Just as some people are gay or bisexual, some people are asexual. If someone is asexual, it means they have no or little interest in sex. They may still feel romantic attraction, but equally, they may not.

There is a wide range of identities on the asexual spectrum, from people who experience no sexual or romantic attraction to people who engage in sexual contact under some conditions. Many asexual people form meaningful, lasting relationships, and some get married or have children.

Asexuality is not the same as celibacy or abstinence, both of which mean someone experiences sexual attraction but chooses not to act on it.


Read More

Researchers using a new method of assessing risk factors for prostate cancer have found an intriguing link between a lack of physical activity and an increased risk of this condition.

man jogging in parkShare on Pinterest
New evidence suggests that being physically active could help slash prostate cancer risk.

Prostate cancer is the second most common type of cancer among males both in the United States and worldwide.

According to data from the National Cancer Institute (NCI), by the end of 2019, there will have been an estimated 174,650 new cases of prostate cancer in the U.S. alone.

Despite the number of people that this cancer affects every year, specialists still have insufficient knowledge about the risk factors that may play a role in its development.

The NCI cite a mix of modifiable and nonmodifiable factors, including age, a family history of prostate cancer, and the levels of vitamin E, folic acid, and calcium in the body.

Yet there may be other lifestyle-related factors at play, and investigators are hard at work to uncover them.

Recently, a team of researchers from the University of Bristol and Imperial College London in the United Kingdom — alongside colleagues from other academic institutions across the globe — have used a different approach to try to find out more about prostate cancer risk factors.

In their new study, the findings of which now appear in the International Journal of Epidemiology, the investigators used a method called "Mendelian randomization."

Mendelian randomization allows researchers to look at genetic variations to assess causal relationships between various potential risk factors and the development of certain outcomes — in this case, prostate cancer.

Physical activity may more than halve risk

In their study, the researchers identified potential risk factors for prostate cancer through the World Cancer Research Fund's (WCRF) 2018 systematic review of the evidence.

They also had access to the medical information of 79,148 participants with prostate cancer, as well as 61,106 participants without cancer who acted as the controls.

The analysis revealed that individuals with a genetic variation that increased their likelihood of being physically active had a 51% lower risk of prostate cancer than people who did not have this genetic variation.

Moreover, the researchers explain that "physical activity," in this case, refers to all forms of activity, not just exercise.

Following on from this, the study authors conclude that interventions encouraging males to ramp up their levels of physical activity may have a protective effect against this widespread form of cancer.

"This study is the largest-ever of its kind, which uses a relatively new method that complements current observational research to discover what causes prostate cancer," notes study co-author Sarah Lewis, Ph.D.

"It suggests that there could be a larger effect of physical activity on prostate cancer than previously thought, so will hopefully encourage men to be more active."

Sarah Lewis, Ph.D.

Anna Diaz Font, who is head of research funding at WCRF — which, alongside Cancer Research U.K., funded this study — emphasizes the importance of the current findings.

"Up till now, there has only been limited evidence of an effect of physical activity on prostate cancer. This new study looked at the effect of 22 risk factors on prostate cancer, but the results for physical activity were the most striking," she says.

The study's findings, Diaz Font believes, "will pave the way for even more research, where similar methods could be applied to other lifestyle factors, to help identify ways men can reduce their risk of prostate cancer."


Read More

As the use of marijuana is increasing in the United States, researchers are asking whether the use of this substance — particularly smoking joints — is associated with an increased risk of any form of cancer, and, if so, which.

person smoking a jointShare on Pinterest
A new meta-analysis suggests that there is still no end in sight for the debate around marijuana use and cancer risk.

Marijuana is one of the most widely used drugs in the United States, with more than one in seven adults reporting that they used marijuana in 2017.

Statistical reports project that sales of cannabis for recreational purposes in the U.S. will amount to $11,670 million between 2014 and 2020.

According to recent research, smoking a joint remains one of the main ways in which individuals use marijuana recreationally.

While specialists already know that smoking tobacco cigarettes is a top risk factor for many forms of cancer, it remains unclear whether smoking marijuana can increase cancer risk in a similar way.

To try to find out whether there is a link between recreational marijuana use and cancer, researchers from the Northern California Institute of Research and Education in San Francisco and other collaborating institutions recently conducted a systematic review and meta-analysis of studies assessing this potential association.

In their paper — which appears in JAMA Network Open — the team notes that marijuana joints and tobacco cigarettes share many of the same potentially carcinogenic substances.

"Marijuana smoke and tobacco smoke share carcinogens, including toxic gases, reactive oxygen species, and polycyclic aromatic hydrocarbons, such as benzo[alpha]pyrene and phenols, which are 20 times higher in unfiltered marijuana than in cigarette smoke," write first author Dr. Mehrnaz Ghasemiesfe and colleagues.

"Given that cancer is the second leading cause of death in the United States and smoking remains the largest preventable cause of cancer death (responsible for 28.6% of all cancer deaths in 2014), similar toxic effects of marijuana smoke and tobacco smoke may have important health implications," they go on to emphasize.

'Misinformation — a threat to public health'

Dr. Ghasemiesfe and team identified 25 studies assessing the link between marijuana use and the risk of developing different forms of cancer. More specifically, eight of these studies focused on lung cancer, nine looked at head and neck cancers, seven examined urogenital cancers, and four covered various other forms of cancer.

The studies found associations of different strengths between long-term marijuana use and various forms of cancer.

The researchers note that the study results regarding the link between marijuana lung cancer risk were mixed — so much so that they were unable to pool the data.

For head and neck cancer, the researchers concluded that "ever use," which they define as exposure equivalent to smoking one joint a day for 1 year, did not appear to increase the risk, although the strength of the evidence was low. However, the studies produced mixed findings for heavier users.

There was insufficient evidence to link this drug to a heightened risk of nasopharyngeal carcinoma, oral cancer, or laryngeal, pharyngeal, and esophageal cancers.

Among urogenital cancers, the investigators found that individuals who had used marijuana for more than 10 years appeared to have a higher risk of testicular cancer — more specifically, testicular germ cell tumors. Once again, however, the strength of the existing evidence was low.

There was insufficient evidence that marijuana use was associated with an increased risk of other forms of cancer, including prostate, cervical, penile, and colorectal cancers.

Dr. Ghasemiesfe and colleagues note that the studies that they had access to had many limitations, including numerous methodological problems and an insufficient number of participants who reported high levels of marijuana use.

Going forward, the team suggests that there is an urgent need for better quality studies assessing the potential relationship between marijuana and cancer. The researchers conclude:

"Misinformation [on this topic] may constitute an additional threat to public health; cannabis is being increasingly marketed as a potential cure for cancer in the absence of evidence, with enormous engagement in this misinformation on social media, particularly in states that have legalized recreational use."

"As marijuana smoking and other forms of marijuana use increase and evolve, it will be critical to develop a better understanding of the association of these different use behaviors with the development of cancers and other chronic conditions and to ensure accurate messaging to the public," they add.


Read More

Testosterone injections are hormone treatments. Their primary use is as a treatment for sexual dysfunction in males and postmenopausal symptoms in females with a testosterone deficiency. Transgender men and nonbinary people may also use testosterone injections as part of masculinizing therapy.

Testosterone injections are safe for many people, but they can have side effects. The side effects may be different depending on the reason why the person is using the injections.

Although testosterone injections can help for low testosterone due to medical conditions, the Food and Drug Administration (FDA) do not recommend using testosterone to treat natural aging-related testosterone changes as it may increase the risk of certain health issues.

Keep reading for more information on testosterone injections, including their uses, safety, and potential side effects.

a doctor discussing testosterone injections with a patientShare on Pinterest
A doctor may recommend testosterone injections to treat sexual dysfunction in males.

Testosterone injections are injections of isolated testosterone. This hormone is present in both males and females, but the levels are naturally higher in males.

Testosterone therapy is becoming more common in the United States. Before recommending long-term testosterone therapy, doctors should make sure that the person understands and has weighed up the risks and benefits.

The following sections look at the uses of testosterone injections.

Treating low testosterone levels in males

Doctors may recommend testosterone injections to treat males with low testosterone levels. Low testosterone production by the testicles is called hypogonadism.

Low testosterone can have negative effects. The symptoms of low testosterone in males include a lower sperm count, a decrease in bone or muscle mass, increased body fat, and erectile dysfunction. Normal total testosterone levels in the bloodstream in healthy adult males are 280–1,100 nanograms per deciliter (ng/dl).

When treating hypogonadism, testosterone therapy can have the following benefits:

  • improved sexual function
  • increased lean muscle mass and strength
  • improved mood
  • better cognitive function
  • possible reduction in osteoporosis

It is important to note that this therapy treats the symptoms of low testosterone rather than the underlying cause.

Anyone who suspects that they may have low testosterone can see a doctor for a diagnosis. However, the symptoms are quite general and could be due to other conditions or lifestyle factors.

Not all males with low testosterone will need treatment, and it is not always safe. The FDA have approved testosterone replacement therapy only for males with low testosterone due to disorders of the testicles, brain, or pituitary gland and not for natural age-related declines.

Read about other ways to increase testosterone levels and eight foods that may increase testosterone here.

Testosterone therapy in females

Testosterone therapy is more controversial in females than in males.

Normal total testosterone levels in healthy adult females are 15–70 ng/dl. Low testosterone in females can cause fertility problems, irregular periods, vaginal dryness, and a low sex drive. Despite this, doctors do not often recommend testosterone injections to treat low testosterone in females, as they can have masculinizing effects.

However, doctors may recommend testosterone therapy to help with hypoactive sexual desire disorder in females after menopause. Research has not supported their use for other signs and symptoms that people may experience after menopause, which include anxiety, mood changes, weight gain, and reduced bone density.

Currently, the FDA have not approved any products for testosterone therapy in females. Additionally, in the USA, there are no readily available formulations that provide the recommended treatment dose of 300 micrograms per day for females. As a result, a female will typically need a compounding pharmacy to fill the prescription.

Masculinizing hormone therapy

Testosterone therapy allows people to develop a more masculine appearance. Transgender men, nonbinary people, and other individuals may choose to use testosterone injections as part of a gender transition. This use of testosterone injections is known as masculinizing hormone therapy.

Testosterone therapy helps a person develop male sexual characteristics and reduce female characteristics, and it can lead to any of the following changes:

  • changes in emotional and social functioning
  • growing more facial hair
  • increased body hair
  • increased acne
  • a deeper voice
  • a receding hairline with male pattern baldness
  • changes in the location of body fat
  • increases in muscle mass
  • absence of menstrual periods

These testosterone therapy regimens are similar to those that treat hypogonadism in males. Taking testosterone injections once a week may be the best way to keep the levels of this hormone even.

Testosterone injections can come in several varieties. These include:

  • testosterone cypionate (Depo-Testosterone)
  • testosterone enanthate (Xyosted and also available in its generic form)
  • testosterone undecanoate (Aveed, which is a long acting formulation)

When a person receives a testosterone injection, the hormone directly enters the body through the muscle. People can choose between two methods:

  • self-administering the injections at home, using a home injection kit to inject the hormone into the thigh
  • having a doctor administer them into the buttocks muscle during a visit to the doctor's office

When having testosterone injections, people will usually visit their doctor every few months for monitoring. Treatments could last for a lifetime or be short-term, depending on the individual's circumstances.

Testosterone injections may be safe for many people when they follow a doctor's instructions. However, research has also linked testosterone therapy with several side effects and possible complications.

Possible negative effects of testosterone therapy may include:

  • an increased risk of cardiovascular complications
  • worsened symptoms in the lower urinary tract
  • polycythemia, a rare type of blood cancer
  • an increased risk of venous thrombosis

Some people may have an allergic reaction to testosterone injections. For example, testosterone undecanoate may cause a serious allergic reaction or breathing issues following the injection. Symptoms can include breathing problems, dizziness, and skin rashes.

Other forms of testosterone, including testosterone enanthate, may increase blood pressure, which can raise the risk of a stroke or heart attack.

People who have had strokes, heart attacks, heart disease, or high blood pressure should make the doctor aware of this before starting testosterone injections, as they may have a higher risk of complications.

If someone experiences any of the following symptoms after a testosterone injection, they should seek emergency medical attention:

  • shortness of breath
  • slow or difficult speech
  • chest pain
  • weakness or numbness in an arm or leg
  • pain in the arms, neck, back, or jaw
  • dizziness
  • faintness

If a doctor prescribes male testosterone injections to an adolescent to treat a constitutional delay of growth and puberty, the goal will be to achieve an accelerated growth spurt during puberty. This therapy should not affect the final adult height that the adolescent reaches.

People may experience some mild side effects from testosterone injections, such as:

  • breast enlargement or pain
  • acne
  • a deeper voice
  • tiredness
  • hoarseness
  • back pain
  • redness, bruising, pain, bleeding, or hardness at the injection site
  • trouble sleeping or staying awake
  • weight gain
  • joint pain
  • mood swings
  • headaches

A person should speak to their doctor if they experience more serious side effects, such as:

  • nausea or vomiting
  • lower leg pain, redness, or warmth
  • swelling of the hands, ankles, feet, or lower legs
  • trouble breathing
  • yellowing of the eyes or skin
  • excessively long lasting erections
  • changes in urination, such as difficulty urinating, increased frequency, weak flow, urinary urgency, or blood in the urine
  • severe pain in the upper right part of the abdomen
  • mood changes, including depression, anxiety, or feeling suicidal

Doctors may prescribe testosterone injections to treat low testosterone due to certain medical conditions in males. It does not cure the underlying condition, but it may help alleviate some of the symptoms. People can also use these injections to treat sexual dysfunction resulting from bodily changes after menopause or as part of masculinizing hormone therapy.

People should be aware of the possible serious complications of using testosterone in both the short-term and long-term. Doctors should do a thorough evaluation and, if testosterone replacement therapy is an option, discuss the benefit and risks with the person before prescribing it.

It is important to follow a doctor's instructions at all times to reduce any risks.


Read More

Male discharge is any fluid that comes from the urethra other than urine.

The urethra is a narrow tube that carries urine from the bladder and semen from the ejaculatory ducts. These fluids travel along the urethra before exiting the body at the urethral opening in the tip of the penis.

Some types of discharge are natural and help protect or lubricate the penis. Others may occur as a result of an underlying health condition.

These may be accompanied by symptoms such as pain, irritation, or an unpleasant smell.

This article describes the types of penile discharge that doctors consider normal and those they consider to be abnormal. We outline the symptoms associated with each and provide information on when to see a doctor.

Normal discharge includes preejaculate and ejaculate. These are released from the tip of the penis during sexual arousal and intercourse.

Although not strictly penile discharge, smegma is another substance that may build up around the head of the penis.

The sections below will cover these types of normal male discharge in more detail.

Preejaculate

Preejaculatory fluid, or precum, is a thick alkaline mucus produced in the bulbourethral glands. The bulbourethral glands, or Cowper's glands, are two pea-sized glands located below the prostate gland.

During sexual stimulation, the bulbourethral glands secrete up to 4 milliliters (ml) of preejaculate into the urethra.

Preejaculatory fluid may:

  • function as a lubricant for semen
  • lubricate the tip of the penis during intercourse
  • neutralize acidity left by urine residue in the urethra
  • neutralize vaginal acidity

Whereas the bulbourethral glands release preejaculatory fluid, it is the testes that release sperm. Nonetheless, a 2011 study found that some preejaculate contains live sperm. Preejaculatory samples from the participants contained up to 23 million sperm.

Researchers are not sure whether preejaculate is contaminated immediately before ejaculation or contaminated with sperm leftover from a previous ejaculation.

Ejaculate

Ejaculate, or semen, is a milky, cloudy fluid that travels through the urethra and out of the penis following sexual stimulation. This process is called ejaculation, and it usually happens during orgasm.

Healthy sperm concentrations in semen are around 15–150 million sperm per ml of semen.

Sperm are produced in the testes. They then mature inside ducts located behind the testes. These ducts are called the epididymis and the vas deferens.

During sexual stimulation, the sperm mix with seminal fluid to form semen. Seminal fluid is a whitish liquid produced by the prostate glands and glands called the seminal vesicles.

Sperm make up a small part of semen. Semen is composed of the following:

  • 1–5% sperm
  • around 5% secretions from the bulbourethral glands
  • 15–30% secretions from the prostate
  • fluid from the seminal vesicle

Smegma

Smegma is a thick, white substance made up of skin cells, skin oils, and moisture. It is secreted by the sebaceous glands in the skin around the genitals. In males, smegma tends to build up between the head of the penis and the foreskin.

Smegma is a natural lubricant that helps keep the genitals moist and enables the foreskin to retract during sexual intercourse.

However, smegma buildup may produce a foul odor and can act as a breeding ground for bacteria. Washing the penis once per day with clean, warm water will help reduce smegma buildup.

That said, males should avoid washing the penis too frequently with soap or shower gel, as these products can cause irritation and soreness.

The presence of male discharge at times other than sexual stimulation may signal an underlying health concern. We describe some of these in the sections below.

Balanitis

Balanitis refers to inflammation of the skin around the head of the penis. When the inflammation also affects the foreskin, it is known as balanoposthitis.

Some symptoms of balanitis include:

  • thick, lumpy discharge that is either white or yellow
  • an unpleasant smell
  • a red, inflamed rash or swelling
  • irritation, soreness, itching, or burning
  • pain when urinating

Many factors can cause balanitis, including:

  • Poor hygiene: The area underneath the foreskin requires regular cleaning. Dead skin cells, urine residue, and sweat provide the ideal environment for irritation-causing bacteria to breed.
  • Allergies: Urine, soaps, condoms, and lubricants can irritate the skin on the penis.
  • Skin conditions: Eczema, psoriasis, or lichen sclerosus may cause redness and inflammation.
  • Infection: Bacterial or fungal infections can make the head of the penis sore, tender, and itchy.
  • Sexually transmitted infections (STIs): STIs such as herpes simplex virus (HSV) can cause blistering and inflammation in the area around the genitals.

Both circumcised and uncircumcised males can develop balanitis. However, one 2017 study found that balanitis is 68% less prevalent among circumcised males than uncircumcised males.

Trichomoniasis

Trichomoniasis is a common infection that affects around 3.7 million people in the United States. The parasite Trichomonas vaginalis causes trichomoniasis.

Around 70% of people with trichomoniasis do not experience any symptoms. If symptoms do occur in males, they may include:

Urethritis

Urethritis is characterized by inflammation of the urethra, and it can be infectious or noninfectious.

Urethritis often develops as a result of an STI. If it develops due to gonorrhea, it is called gonococcal urethritis. If the cause is unknown, it is called nongonococcal urethritis.

Over 40% of people with nongonococcal urethritis do not experience symptoms.

However, some males may experience the following symptoms:

  • cloudy or white discharge from the tip of the penis
  • irritation and soreness at the urethral opening
  • a burning sensation when urinating
  • a frequent need to urinate
  • testicular pain or swelling

The following pathogens can also cause urethritis:

  • Neisseria gonorrhoeae
  • Chlamydia trachomatis
  • Mycoplasma genitalium
  • Trichomonas vaginalis
  • HSV
  • Epstein-Barr virus
  • adenovirus

C. trachomatis is the most common cause of nongonococcal urethritis. It accounts for around 15–40% of cases.

Urethritis can also result from vigorous sex, masturbation, and urinary tract infections (UTIs).

UTIs

UTIs are a common type of bacterial infection. They affect part of the urinary system. The urinary system includes the bladder, kidneys, and urethra.

UTIs occur when bacteria from the skin or rectum enter the urethra and cause infection in the urinary tract.

UTIs tend to be more common in females, who have shorter urethras that are closer to the rectum. This makes it easier for bacteria to enter the urethra and reach the bladder and kidneys.

However, males can also develop UTIs. Males with a UTI may experience symptoms such as:

  • cloudy urine that contains pus
  • red, pink, or brown urine that contains blood
  • pain or a burning sensation when urinating
  • a need to urinate more than usual
  • strong-smelling urine
  • nausea or vomiting

Factors that increase the risk of developing a UTI include:

A person cannot pass a UTI to a sexual partner. However, the person may experience pain and discomfort during sex.

STIs

STIs can spread from person to person as a result of unprotected sexual activity and genital contact.

STIs that may cause abnormal penile discharge include:

Chlamydia

Chlamydia is the most reported STI in the U.S. However, most people with chlamydia are unaware that they have it, as it often does not cause any symptoms.

C. trachomatis is the cause of chlamydia. These bacteria can infect the urethra, rectum, and throat.

In males, chlamydia may cause the following symptoms:

  • white, cloudy, or watery penile discharge
  • itching or burning at the tip of the penis
  • a burning sensation when urinating
  • testicular pain

Gonorrhea

Gonorrhea is a common infection in the U.S., particularly among adolescents and young adults.

N. gonorrhoeae is the cause of gonorrhea. These bacteria can infect the urethra and rectum. Sometimes, the infection may also affect the eyes, throat, and joints.

Symptoms of gonorrhea in males include:

  • white, yellow, or green penile discharge
  • inflammation of the foreskin
  • pain or a burning sensation when urinating
  • swelling in one testicle

A male should see a doctor if they experience discharge from the penis that is not any of the following:

  • urine
  • preejaculate
  • ejaculate
  • smegma

To determine what is causing the penile discharge, a doctor may:

  • ask about the person's symptoms
  • make a note of their medical and sexual history
  • examine the affected area of the penis
  • ask for a urine sample to identify signs of a UTI
  • swab the affected area and analyze the swab for bacteria and viruses

After identifying the cause of the discharge, the doctor will determine the best course of treatment.

Discharge from the penis that happens during sexual arousal, as a result of sexual intercourse, and after ejaculation is normal.

Abnormal discharge tends to:

  • have an unusual color
  • have a foul odor
  • occur without sexual activity
  • be accompanied by pain, burning, or other symptoms

In these instances, the discharge could be a sign of a medical condition that needs evaluation and treatment. It is important to make an appointment with a doctor.


Read More
Older Posts

Páginas

  • Página principal
  • Disclaimer
  • Privacy Policy

Labels

Eye Health Latest News Men Health Women Health

recent posts

Blog Archive

  • enero (18)

Created with by BeautyTemplates | Distributed by blogger templates